biomedical-research
(6)
The Scientists Who Learned to Speak Washington
A small Washington firm found a lucrative gap between the laboratory and the legislature. Its job is to make good science legible to the people who fund it.
The Quiet Machinery Behind the Public Health Message
Lumina Corps makes complicated health information usable - one conference, toolkit, website, and carefully tested sentence at a time.
Causaly Wants Scientists to Spend Less Time Hunting for Evidence
The London company is turning biomedical literature into research workflows. Its real test is whether scientists can inspect the evidence, challenge the answer and make a better decision.
The Tiny Vaccine Lab With a $10 Million Head Start - and No Human Trial Yet
TechnoVax has spent two decades making convincing copies of dangerous viruses - minus the genes that make them dangerous. Its science has attracted roughly $10 million in federal awards; the harder experiment is turning a tiny lab's preclinical wins into a product people can actually receive.
Sus Clinicals, Inc.
Sus Clinicals, Inc. is a Cincinnati- and Chicago-based biotechnology company commercializing the Oncopig Cancer Model - a genetically engineered pig that develops human-like tumors on demand. Billed as the only FDA-cleared large animal cancer platform, the Oncopig carries KRAS and TP53 mutations found in more than half of human cancers, giving drug, device, and diagnostic developers a predictive testing ground that sits between the mouse and the human clinical trial. Alongside live animal supply, the company runs histology services and a tumor-tissue biorepository, and partners with CROs across the US and Europe.
Chan Zuckerberg Initiative
The Chan Zuckerberg Initiative (CZI) is a philanthropy and technology organization founded in 2015 by Priscilla Chan and Mark Zuckerberg, structured as an LLC. Once spanning education, science, justice reform and housing, CZI has refocused on a single audacious goal: helping scientists cure, prevent or manage all disease by the end of the century. Its flagship CZ Biohub network now builds AI 'virtual cell' models, generates massive biological datasets, and ships free open-source tools so researchers everywhere can move faster.